Dapoxetine (INN, brand name Priligy) is a short-acting SSRI drug for the treatment of premature ejaculation in men. Dapoxetine is the only drug with regulatory approval for such treatment. Currently, it's approved for use in several European countries including Finland, Sweden, Portugal, Austria and Germany. Dapoxetine is also being considered for approval in other European countries and in the United States where it's currently in Phase III of the Food and Drug Administration (FDA) approval pr… (More on Dapoxetine)